NervGen Pharma (NGENF) Short Interest Ratio & Short Volume → Biden to Launch “FedNOW” [Move Your Money Now] (From Priority Gold) (Ad) Free NGENF Stock Alerts $1.70 +0.10 (+6.25%) (As of 05/3/2024 ET) Add Compare Share Share Short InterestStock AnalysisChartHeadlinesShort InterestStock AnalysisChartHeadlinesShort Interest NervGen Pharma Short Interest DataCurrent Short Volume68,900 sharesPrevious Short Volume416,300 sharesChange Vs. Previous Month-83.45%Dollar Volume Sold Short$103,350.00Short Interest Ratio / Days to Cover0.6Last Record DateApril 15, 2024Outstanding Shares61,770,000 sharesPercentage of Shares Shorted0.11%Today's Trading Volume92,675 sharesAverage Trading Volume69,813 sharesToday's Volume Vs. Average133% Short Selling NervGen Pharma ? Sign up to receive the latest short interest report for NervGen Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatNGENF Short Interest Over TimeNGENF Days to Cover Over TimeNGENF Percentage of Float Shorted Over Time Ad Allegiance GoldCould Your Accounts Be Frozen?The US Dollar Is "Finished" A deteriorating economy, global instability, and a weakened banking system have pushed the U.S. financial system to the brink, imperiling the value of your savings and investments.Get your Free Wealth Protection Kit NervGen Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202468,900 shares $103,350.00 -83.5%N/A0.6 $1.50 3/31/2024416,300 shares $670,243.00 +67.8%N/A1.3 $1.61 3/15/2024248,100 shares $474,069.48 +151.4%N/A2.3 $1.91 2/29/202498,700 shares $251,685.00 +296.4%N/A0.9 $2.55 2/15/202424,900 shares $63,412.83 +38.3%N/A0.1 $2.55 1/15/202444,600 shares $88,085.00 -1.8%N/A0.3 $1.98 Get the Latest News and Ratings for NGENF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for NervGen Pharma and its competitors with MarketBeat's FREE daily newsletter. 12/31/202345,400 shares $92,616.00 +1,791.7%N/A0.2 $2.04 12/15/20232,400 shares $2,955.60 +700.0%N/A0 $1.23 11/30/2023300 shares $393.00 -96.0%N/A0 $1.31 11/15/20237,400 shares $10,567.20 +13.9%N/A0.1 $1.43 10/31/20236,500 shares $8,710.00 +333.3%N/A0.1 $1.34 10/15/20231,500 shares $1,943.40 -81.9%N/A0 $1.30 9/30/20238,300 shares $11,715.45 +6.4%N/A0.2 $1.41 9/15/20237,800 shares $11,934.00 -57.1%N/A0.1 $1.53 8/31/202318,200 shares $27,614.86 +237.0%N/A0.2 $1.52 8/15/20235,400 shares $7,162.02 -79.6%N/A0.1 $1.33 7/31/202326,500 shares $34,185.00 +6.4%N/A1 $1.29 7/15/202324,900 shares $32,619.00 -2.7%N/A0.8 $1.31 6/30/202325,600 shares $31,744.00 -20.0%N/A0.4 $1.24 6/15/202332,000 shares $41,600.00 -32.9%N/A1.2 $1.30 5/31/202347,700 shares $62,010.00 +166.5%N/A1.1 $1.30 5/15/202317,900 shares $20,943.00 +96.7%N/A0.4 $1.17 4/30/20239,100 shares $10,556.00 -50.5%N/A0.1 $1.16 4/15/202318,400 shares $24,381.84 +318.2%N/A0.4 $1.33 3/31/20234,400 shares $5,425.20 +7.3%N/A0.1 $1.23 3/15/20234,100 shares $5,104.50 -33.9%N/A0.1 $1.25 2/28/20236,200 shares $8,556.00 +463.6%N/A0.1 $1.38 2/15/20231,100 shares $1,606.00 -38.9%N/A0 $1.46 1/31/20231,800 shares $2,907.00 +200.0%N/A0 $1.62 1/15/2023600 shares $864.00 -83.8%N/A0 $1.44 12/30/20223,700 shares $4,403.00 +516.7%N/A0.1 $1.19 12/15/2022600 shares $720.00 -81.8%N/A0 $1.20 11/30/20223,300 shares $4,686.00 -13.2%N/A0.1 $1.42 11/15/20223,800 shares $4,959.00 +111.1%N/A0.1 $1.31 10/31/20221,800 shares $2,358.00 -56.1%N/A0.1 $1.31 10/15/20224,100 shares $5,084.00 -73.6%N/A0.1 $1.24 9/30/202215,500 shares $20,770.00 +453.6%N/A0.2 $1.34 9/15/20222,800 shares $4,125.24 -42.9%N/A0.1 $1.47 8/31/20224,900 shares $7,399.00 No ChangeN/A0.1 $1.51 7/31/202210,500 shares $17,640.00 -34.4%N/A0.1 $1.68Never use this word on your phone (FBI could be watching) (Ad)This report sent a chill down my spine. Turns out, as part of their Jan. 6th investigation, the Feds are flagging Americans who typed these ordinary words as part of their banking transactions...Watch my unredacted video about what I think is coming next right here NGENF Short Interest - Frequently Asked Questions What is NervGen Pharma's current short interest? Short interest is the volume of NervGen Pharma shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 68,900 shares of NGENF short. Learn More on NervGen Pharma's current short interest. What is a good short interest ratio for NervGen Pharma? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. NGENF shares currently have a short interest ratio of 1.0. Learn More on NervGen Pharma's short interest ratio. Is NervGen Pharma's short interest increasing or decreasing? NervGen Pharma saw a decrease in short interest in April. As of April 15th, there was short interest totaling 68,900 shares, a decrease of 83.4% from the previous total of 416,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does NervGen Pharma's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to NervGen Pharma: Vigil Neuroscience, Inc. (6.18%), FibroGen, Inc. (5.91%), Kinnate Biopharma Inc. (2.01%), NGM Biopharmaceuticals, Inc. (4.52%), Ocuphire Pharma, Inc. (6.17%), LianBio (0.36%), Inovio Pharmaceuticals, Inc. (8.87%), Oramed Pharmaceuticals Inc. (0.91%), Clearside Biomedical, Inc. (0.36%), Sernova Corp. (0.00%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short NervGen Pharma stock? Short selling NGENF is an investing strategy that aims to generate trading profit from NervGen Pharma as its price is falling. NGENF shares are trading up $0.10 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against NervGen Pharma? A short squeeze for NervGen Pharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of NGENF, which in turn drives the price of the stock up even further. How often is NervGen Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including NGENF, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Vigil Neuroscience Short Interest Data FibroGen Short Interest Data Kinnate Biopharma Short Interest Data NGM Biopharmaceuticals Short Interest Data Ocuphire Pharma Short Interest Data LianBio Short Interest Data Inovio Pharmaceuticals Short Interest Data Oramed Pharmaceuticals Short Interest Data Clearside Biomedical Short Interest Data Sernova Short Interest Data Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:NGENF) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldUrgent Nvidia WarningAltimetryThe asset beating inflation by 4xColonial MetalsThe A.I. story nobody is telling you (Read ASAP)TradeSmithHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlace